ArticleTrials2021

Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.

Carinna Hockham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.